Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q4 FY23 results · Jan–Mar 2023
Medplus Health Services reported revenue from operations of ₹1,252.98 crore (up 29.7% from Q4 FY22) and net profit of ₹26.56 crore (up 132.4% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,252.98 | 965.91 | +29.7% | 1,190.31 | +5.3% |
| Other income | 13.69 | 13.05 | +5.0% | 11.36 | +20.5% |
| Total income | 1,266.68 | 978.96 | +29.4% | 1,201.67 | +5.4% |
| Profit before tax | 17.25 | 12.63 | +36.6% | 16.21 | +6.4% |
| Net profit for the period | 26.56 | 11.43 | +132.4% | 13.38 | +98.5% |
| Attributable to shareholders of the company | 26.58 | 11.73 | +126.7% | 13.41 | +98.3% |
| EPS, basic (₹) | 2.24 | 0.99 | +126.3% | 1.12 | +100.0% |
| Net margin (%) | 2.1 | 1.2 | 1.1 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 86.95 | 38.82 | +124.0% | 57.24 | +51.9% |
| Other income | 2.54 | 6.21 | −59.1% | 4.07 | −37.5% |
| Total income | 89.49 | 45.03 | +98.7% | 61.31 | +46.0% |
| Profit before tax | 6.59 | 0.92 | +614.5% | 1.78 | +269.9% |
| Net profit for the period | 5.71 | 0.92 | +519.0% | 0.62 | +820.5% |
| EPS, basic (₹) | 0.15 | 0.08 | +87.5% | 0.15 | +0.0% |
| Net margin (%) | 6.6 | 2.4 | 1.1 |
Consolidated
- Filed with BSE
- 26 May 2023, 14:58 IST
- Board meeting
- 25 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 26 May 2023, 14:58 IST
- Board meeting
- 25 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE